GENEREX BIOTECHNOLOGY CORP

33 HARBOUR SQ, STE 202, TORONTO ONTARIO CANA A1, 4163642551
PHARMACEUTICAL PREPARATIONS

2000 SEC Filings

GENEREX BIOTECHNOLOGY CORP, 10-Q/A, 2000-12-19
GENEREX BIOTECHNOLOGY CORP, 10-Q, 2000-12-15
GENEREX BIOTECHNOLOGY CORP, 8-K/A, 2000-12-06
GENEREX BIOTECHNOLOGY CORP, S-3, 2000-12-04
GENEREX BIOTECHNOLOGY CORP, 10-K, 2000-10-30
GENEREX BIOTECHNOLOGY CORP, 8-K, 2000-10-16
GENEREX BIOTECHNOLOGY CORP, S-3/A, 2000-09-18
GENEREX BIOTECHNOLOGY CORP, 8-K/A, 2000-09-07
GENEREX BIOTECHNOLOGY CORP, 8-K, 2000-09-07
GENEREX BIOTECHNOLOGY CORP, 8-K, 2000-09-06
GENEREX BIOTECHNOLOGY CORP, 8-K, 2000-08-28
GENEREX BIOTECHNOLOGY CORP, S-3, 2000-07-28
GENEREX BIOTECHNOLOGY CORP, 424B3, 2000-07-26
GENEREX BIOTECHNOLOGY CORP, S-3/A, 2000-07-21
GENEREX BIOTECHNOLOGY CORP, S-3, 2000-07-10
GENEREX BIOTECHNOLOGY CORP, POS AM, 2000-06-19
GENEREX BIOTECHNOLOGY CORP, 10-Q, 2000-06-13
GENEREX BIOTECHNOLOGY CORP, 424B3, 2000-05-31
GENEREX BIOTECHNOLOGY CORP, S-3/A, 2000-05-11
GENEREX BIOTECHNOLOGY CORP, 4, 2000-04-07
GENEREX BIOTECHNOLOGY CORP, S-3, 2000-03-29
GENEREX BIOTECHNOLOGY CORP, 8-K, 2000-03-27
GENEREX BIOTECHNOLOGY CORP, 10-Q, 2000-03-14
GENEREX BIOTECHNOLOGY CORP, 8-K, 2000-03-02


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission